Drug Database
Back to search

Netherlands· NL-53d2ef274557

Lacosamide Xiromed 10 mg/ml, stroop

A lacosamide product containing lacosamide, registered in Netherlands by Medical Valley Invest AB. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX18

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLacosamide Xiromed 10 mg/ml, stroopATCN03AX18REGISTER NO.NL-53d2ef274557PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lacosamideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lacosamide is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX18 (lacosamide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search lacosamide products by name

Lacosamide · ATC N03AX18

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lacosamide costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.48 in United States to $3.11 in Switzerland — a ×6.4 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Lacosamide · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.11
  • IT Italy$3.06
  • FR France$1.49
  • US United States$0.48 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LACOSAMIDE
Manufacturer
Medical Valley Invest AB
Country
Netherlands (NL)
ATC code
N03AX18
ATC class
Lacosamide
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    124188

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

62 interactions on record for lacosamide.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lacosamide against other medicinesHow interaction checks work

Lacosamide · interactions on record

62 records

  • 5 severe
  • 32 moderate

Most severe, free to view

  • DolasetronA04AA04severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • SiponimodL04AA42severe

25 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lacosamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lacosamide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Lacopat, Lacopat Packung Zur Behandlungseinleitung
  • Belgium · Lacosamid Hikma, Lacosamide Eg
  • Bulgaria · Канилад, Лакозамид Гриндекс
  • Cyprus · Kanilad, Lacosadel
  • Czechia · Arkvimma, Kanilad
  • Germany · Kanilad, Lackepila
  • Denmark · 200 mg, Lacosamid Opko Health Spain
  • Estonia · Kanilad, Lacosamide Alembic
  • Spain · Balmid, Kanilad
  • Finland · Lacosamide Fresenius Kabi, Lacosamide Grindeks
  • France · Lacosamide Arrow, Lacosamide Biogaran
  • United Kingdom (Northern Ireland) · Lacosamide, Lacosamide Amarox
  • Greece · Anlamyl, Josamec
  • Croatia · Kanilad, Lacosamide Grindeks
  • Hungary · Anlamyl, Arkvimma
  • Ireland · Lacosamide Ascend, Lacosamide Fresenius Kabi
  • Iceland · Josamec, Lacosamide Accord
  • Italy · Lacosamide Aurobindo, Lacosamide Doc
  • Liechtenstein · Lacosamid Fresenius Kabi, Lacosamide Accord
  • Lithuania · Lacosamide Fresenius Kabi, Lacosamide Grindeks
  • Luxembourg · Lacosamide Eg
  • Latvia · Kanilad, Lacosamide Fresenius Kabi
  • Malta · Anlamyl, Kanilad
  • Norway · Lacosamide Accord, Lacosamide Fresenius Kabi
  • Poland · Arkvimma, Epilantin
  • Portugal · Lacosamida Alter, Lacosamida Aristo
  • Romania · Lacosamidă Teva
  • Sweden · Lacomed, Lacosamide 1a Farma
  • Slovenia · Lacosabil, Lacosamide Grindeks
  • Slovakia · Arkvimma, Kanilad

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/48b89d63-cc6b-43fd-b635-ddf84ece27e7
GET /v1/drugs/48b89d63-cc6b-43fd-b635-ddf84ece27e7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stroop",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h124188_smpc.pdf",
  "strength": null,
  "atc_label": "Lacosamide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg124188",
  "excipients": [
    "AARDBEIENSMAAKSTOF",
    "CARMELLOSE NATRIUM (E 466)",
    "CITROENZUUR 1-WATER (E 330)",
    "GLYCEROL 85 PER CENT (E 422)",
    "MACROGOL 4000",
    "MALTOL (E 636)",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "NATRIUMCHLORIDE",
    "PROPYLEENGLYCOL (E 1520)",
    "SORBITOL (E 420)",
    "SUCRALOSE (E 955)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "LACOSAMIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h124188.pdf",
  "authorised_at": "2020/04/22",
  "procedure_number": "SE/H/1904/005",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "124188",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about lacosamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console